Why is Clinitech Lab falling/rising?

As of 01-Sep, Clinitech Laboratory Ltd's stock is currently priced at 52.74, reflecting an increase of 0.24 or 0.46%. The stock has shown a positive trend recently, gaining 5.48% over the last two days, although it has underperformed its sector by 0.4%. In terms of longer-term performance, the stock has declined significantly, with a year-to-date drop of 33.12% and a one-year decline of 41.43%. Notably, the stock's delivery volume has decreased by 80% compared to the five-day average, indicating falling investor participation, which may contribute to its volatility. The stock is trading above its short-term moving averages but remains below its longer-term averages, suggesting mixed signals regarding its price momentum.
Broader market context shows that Clinitech's recent performance contrasts with the benchmark, as the Sensex has declined by 1.56% over the past week while Clinitech has gained 0.65%. This indicates that the stock is performing relatively better than the broader market in the short term. However, the stock's year-to-date performance is significantly worse than the Sensex, which has risen by 2.85% in the same period. The erratic trading pattern, with the stock not trading on one day out of the last twenty, further complicates its market position, suggesting potential liquidity issues despite being liquid enough for trading.